Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | 0.00% | 0.00% | -98.19% |
Jul. 03 | Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024 | CI |
Jun. 21 | Navidea Biopharmaceuticals, Inc. Announces Board Resignations | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-98.19% | 99.99K | |
+23.50% | 47.07B | |
+47.30% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+47.29% | 14.37B | |
+41.91% | 13.45B | |
-1.02% | 12.03B |
- Stock Market
- Equities
- NAVB Stock
- News Navidea Biopharmaceuticals, Inc.
- Transcript : Navidea Biopharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 11, 2021